These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 30173002)

  • 1. The effects of a muscarinic receptor 1 gene variant on cortical thickness and surface area in schizophrenia.
    Carruthers SP; Gurvich CT; Cropley VL; Pantelis C; Bousman C; Lenroot RK; Bruggemann JM; Weickert T; ; Rossell SL
    Psychiatry Res Neuroimaging; 2018 Oct; 280():62-64. PubMed ID: 30173002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a muscarinic receptor 1 gene variant on grey matter volume in schizophrenia.
    Cropley VL; Scarr E; Fornito A; Klauser P; Bousman CA; Scott R; Cairns MJ; Tooney PA; Pantelis C; Dean B
    Psychiatry Res; 2015 Nov; 234(2):182-7. PubMed ID: 26481978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of a muscarinic receptor 1 gene variant on executive and non-executive cognition in schizophrenia spectrum disorders.
    Carruthers SP; Cropley V; Bousman C; Everall IP; Neill E; Pantelis C; Sumner PJ; Tan EJ; ; Bozaoglu K; Thomas EHX; Van Rheenen TE; Gurvich CT; Rossell SL
    Psychiatry Res; 2019 Mar; 273():178-180. PubMed ID: 30654302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered grey matter volume and cortical thickness in patients with schizo-obsessive comorbidity.
    Wang YM; Zou LQ; Xie WL; Yang ZY; Zhu XZ; Cheung EFC; Sørensen TA; Møller A; Chan RCK
    Psychiatry Res Neuroimaging; 2018 Jun; 276():65-72. PubMed ID: 29628272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between plasma levels of clozapine and N-desmethyclozapine as well as M1 receptor polymorphism with cognitive functioning and associated cortical activity in schizophrenia.
    Kır Y; Baskak B; Kuşman A; Sayar-Akaslan D; Özdemir F; Sedes-Baskak N; Süzen HS; Baran Z
    Psychiatry Res Neuroimaging; 2020 Sep; 303():111128. PubMed ID: 32593951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased MRI-based cortical grey/white-matter contrast in sensory and motor regions in schizophrenia and bipolar disorder.
    Jørgensen KN; Nerland S; Norbom LB; Doan NT; Nesvåg R; Mørch-Johnsen L; Haukvik UK; Melle I; Andreassen OA; Westlye LT; Agartz I
    Psychol Med; 2016 Jul; 46(9):1971-85. PubMed ID: 27049014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of muscarinic m1 receptor genetic polymorphisms with psychiatric symptoms and cognitive function in schizophrenic patients.
    Liao DL; Hong CJ; Chen HM; Chen YE; Lee SM; Chang CY; Chen H; Tsai SJ
    Neuropsychobiology; 2003; 48(2):72-6. PubMed ID: 14504414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic M1 receptor sequence: preliminary studies on its effects on cognition and expression.
    Scarr E; Sundram S; Deljo A; Cowie TF; Gibbons AS; Juzva S; Mackinnon A; Wood SJ; Testa R; Pantelis C; Dean B
    Schizophr Res; 2012 Jun; 138(1):94-8. PubMed ID: 22391213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia.
    Barker V; Bois C; Johnstone EC; Owens DG; Whalley HC; McIntosh AM; Lawrie SM
    Psychol Med; 2016 Mar; 46(4):891-6. PubMed ID: 26654172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of grey matter volume and thickness for analysing cortical changes in chronic schizophrenia: a matter of surface area, grey/white matter intensity contrast, and curvature.
    Kong L; Herold CJ; Zöllner F; Salat DH; Lässer MM; Schmid LA; Fellhauer I; Thomann PA; Essig M; Schad LR; Erickson KI; Schröder J
    Psychiatry Res; 2015 Feb; 231(2):176-83. PubMed ID: 25595222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphological changes in gray matter volume correlate with catechol-O-methyl transferase gene Val158Met polymorphism in first-episode treatment-naïve patients with schizophrenia.
    Li ML; Xiang B; Li YF; Hu X; Wang Q; Guo WJ; Lei W; Huang CH; Zhao LS; Li N; Ren HY; Wang HY; Ma XH; Deng W; Li T
    Neurosci Bull; 2015 Feb; 31(1):31-42. PubMed ID: 25564193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate receptor δ 1 (GRID1) genetic variation and brain structure in schizophrenia.
    Nenadic I; Maitra R; Scherpiet S; Gaser C; Schultz CC; Schachtzabel C; Smesny S; Reichenbach JR; Treutlein J; Mühleisen TW; Deufel T; Cichon S; Rietschel M; Nöthen MM; Sauer H; Schlösser RG
    J Psychiatr Res; 2012 Dec; 46(12):1531-9. PubMed ID: 23017809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in COMT and PRODH is associated with brain anatomy in patients with schizophrenia.
    Zinkstok J; Schmitz N; van Amelsvoort T; Moeton M; Baas F; Linszen D
    Genes Brain Behav; 2008 Feb; 7(1):61-9. PubMed ID: 17504246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure.
    Bohlken MM; Brouwer RM; Mandl RC; Kahn RS; Hulshoff Pol HE
    Schizophr Bull; 2016 Sep; 42(5):1167-75. PubMed ID: 27056715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of MIR137 on white matter fractional anisotropy and cortical surface area in individuals with familial risk for psychosis.
    Vogel BO; Lett TA; Erk S; Mohnke S; Wackerhagen C; Brandl EJ; Romanczuk-Seiferth N; Otto K; Schweiger JI; Tost H; Nöthen MM; Rietschel M; Degenhardt F; Witt SH; Meyer-Lindenberg A; Heinz A; Walter H
    Schizophr Res; 2018 May; 195():190-196. PubMed ID: 28958479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited Evidence for Association of Genome-Wide Schizophrenia Risk Variants on Cortical Neuroimaging Phenotypes.
    Voineskos AN; Felsky D; Wheeler AL; Rotenberg DJ; Levesque M; Patel S; Szeszko PR; Kennedy JL; Lencz T; Malhotra AK
    Schizophr Bull; 2016 Jul; 42(4):1027-36. PubMed ID: 26712857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic variation in FOXP2 alters grey matter concentrations in schizophrenia patients.
    Španiel F; Horáček J; Tintěra J; Ibrahim I; Novák T; Čermák J; Klírová M; Höschl C
    Neurosci Lett; 2011 Apr; 493(3):131-5. PubMed ID: 21334420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor.
    Scarr E; Udawela M; Thomas EA; Dean B
    Mol Psychiatry; 2018 Feb; 23(2):295-303. PubMed ID: 27801890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A polymorphism of the methylenetetrahydrofolate reductase gene confers susceptibility to schizophrenia and related brain changes.
    Ota M; Sato N; Yoshida F; Hattori K; Hidese S; Teraishi T; Kunugi H
    Schizophr Res; 2019 Jun; 208():462-464. PubMed ID: 30852115
    [No Abstract]   [Full Text] [Related]  

  • 20. Common genetic variants have associations with human cortical brain regions and risk of schizophrenia.
    Bi X; Feng L; Wang S; Lin Z; Li T; Zhao B; Zhu H; Zhang H
    Genet Epidemiol; 2019 Jul; 43(5):548-558. PubMed ID: 30941828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.